Notification for least-developed countries under Canada's Access to Medicines Regime
Countries must disclose the following information to the appropriate authority when planning to use the Regime:
- The name and quantity of the drug or medical device needed; and
- A declaration that the product is not patented in the importing country; or
- If the product is patented in the importing country, a declaration that the country will or has issued a compulsory licence authorizing it to use the product.
Least-developed countries that are not members of the WTO are also required to declare that they will adopt measures to prevent diversion of the products to unintended markets.
For a graphic illustration of the notification process, see the process map for Schedule 2 countries.
Report a problem or mistake on this page
- Date modified: